Navigation Links
Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
Date:8/8/2012

countries in Eurasia; Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan; and Actelion Pharmaceuticals Ltd has development and commercial rights for XIAFLEX in Canada, Australia, Brazil and Mexico.  Auxilium has three projects in clinical development. XIAFLEX is in phase III of development for the treatment of Peyronie's Disease. Collagenase clostridium histolyticum ("CCH") is in phase IIa of development for the treatment of Frozen Shoulder syndrome (adhesive capsulitis) and phase Ib of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium also has rights to pursue additional indications for CCH. For additional information, visit http://www.auxilium.com

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the Company's intention to present at the Canaccord Genuity 32nd Annual Growth Conference; and products in development for Peyronie's disease, Frozen Shoulder syndrome and cellulite; and all other statements containing projections, statements of future performance or expectations, our beliefs or statements of plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in t
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
3. Auxilium Announces Appointments to Enhance Leadership Team
4. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
5. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
8. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
9. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
10. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
11. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Saddleback Memorial Medical ... recently became the first hospital on the West Coast ... This new surgical option provides women with a state-of-the-art, ... Marc Winter , M.D., a highly ... surgeon and medical director of minimally invasive surgery at ...
(Date:5/23/2013)... , May 23, 2013 Z Trim Holdings, ... ingredients to a variety of industries, announced that Chef ... panel discussion at this year,s National Restaurant Association ("NRA") ... on behalf of the Research Chefs Association.  Chef Ryan ... The Good, the Bad and the Ugly," joining four ...
(Date:5/23/2013)... DIEGO , May 23, 2013  Verenium Corporation ... company focused on the development and commercialization of high-performance ... , Chief Financial Officer, will present at two upcoming ... Mr. Black will present at the Second Annual Marcum ... the Grand Hyatt Hotel in New York City.  The ...
(Date:5/23/2013)... African Ancestry , Inc., ... of African descent, today announced new product enhancements ... of all races, myDNAmix determines various ancestries included ... Indigenous Americas (Native American), East Asia, West Sub-Saharan ... , Originally launched in late 2011, the enhanced ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3
... HARBIN, China , May 12 /PRNewswire-Asia-FirstCall/ ... or "the Company") (Nasdaq: CSKI ), a leading,fully ... China ,("PRC"), today provided an update on the commercialization ... research and customer feedback, the,Company estimates aggregate incremental 2010 ...
... Institute,s Research and Development will Accelerate Lower Cost Wireless Health Solutions ... SAN ... Foundation today announced a grant of $20 million to support ... in March 2009 with an initial $45 million ...
... May 12 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... and operational highlights for the quarter ended March 31, 2010 ... "We ... both improved our understanding of REOLYSIN(R),s mechanism of action and provided ...
Cached Biology Technology:China Sky One Medical Provides Sales Forecast for 13 New Products 2China Sky One Medical Provides Sales Forecast for 13 New Products 3China Sky One Medical Provides Sales Forecast for 13 New Products 4Gary and Mary West Foundation Grants $20 Million to Advance Engineering Efforts Within the West Wireless Heath Institute 2Gary and Mary West Foundation Grants $20 Million to Advance Engineering Efforts Within the West Wireless Heath Institute 3Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 2Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 3Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 4Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 5Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 6Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 7Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 8Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results 9
(Date:5/22/2013)... NEW YORK CITY, May 22, 2013 U.S. Forest ... multi-disciplinary team that, with funding from the TKF Foundation, ... spaces help communities and individuals recover from tragedy. , ... is one of six projects selected for grant funding. ... spaces and sacred spaces in recovery and resiliency, the ...
(Date:5/22/2013)... a major new effort to educate the public and ... with clean water that looms ahead in the 21st ... the current edition of Chemical & Engineering News ... (ACS), the world,s largest scientific society. , Bassam Z. ... Schnoor, Ph.D., explain that shortages of reliable supplies of ...
(Date:5/22/2013)... DNA can endanger the whole organism, as they may ... (LMU) in Munich now report how byproducts of respiration ... The DNA in our cells controls the form and ... instructions for this are encoded in the linear sequence ... adenine (A), cytosine (C), guanine (G) and thymine (T). ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2DNA damage: The dark side of respiration 2
... Plays well with others. That popular phrase on ... level in higher education these days, as experts in ... address some of society,s biggest challenges, from a warming ... different disciplines and institutions collaborate? How do they work ...
... model of gastritis and stomach cancer, researchers from the Massachusetts ... pylori (H. pylori) infections reverses damage to the lining of ... May 1 issue of Cancer Research, a journal of the ... should lay to rest any question about whether and ...
... Relatively inexpensive interventions were effective in helping health care ... mothers during labor and delivery, reducing bleeding and sometimes ... University of North Carolina at Chapel Hill School of ... Journal of Medicine. Using teaching techniques that employed ...
Cached Biology News:Biologists are from Mars, chemists are from Venus? 2Biologists are from Mars, chemists are from Venus? 3Early treatment of stomach infection may prevent cancer 2Early treatment of stomach infection may prevent cancer 3More than words: childbirth training change improves safety, cuts unnecessary procedures 2
Request Info...
Request Info...
... The product contains 5 ml ... release cells from Dynabeads CD19 (Pan ... Dynabeads CD19 (Pan B) and released ... phenotypically unaltered. Cells are suitable for ...
... Kit #4 detects apoptosis on the ... permeability of cell membranes. This kit contains ... iodide nucleic acid stains. YO-PRO-1 stain selectively ... cells and labels them with moderate green ...
Biology Products: